Trials / Conditions / AChR Myasthenia Gravis
AChR Myasthenia Gravis
3 registered clinical trials studyying AChR Myasthenia Gravis — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod NCT06860633 | University of Colorado, Denver | Phase 4 |
| Recruiting | Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis NCT06106672 | COUR Pharmaceutical Development Company, Inc. | Phase 1 / Phase 2 |
| Terminated | Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravi NCT03579966 | Catalyst Pharmaceuticals, Inc. | Phase 3 |